Check GLP-1 ad wording before the platform does.

We now compound semaglutide for weight loss.

• Blocks approvalCG-RFA-006Also matches CG-CMP-001, CG-PLT-011, CG-PLT-012, CG-PLT-034

  Marketing semaglutide, tirzepatide or peptides for weight loss as research chemicals or as the same ingredient as a brand-name drug sells an unapproved new drug and implies equivalence to an approved product.

  Source. FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance

  Safer wording. Do not market compounded or research peptides for weight loss, and do not claim equivalence with Ozempic, Wegovy, Mounjaro or Zepbound.

Compounded semaglutide, no prescription needed.

• Blocks approvalCG-REG-007Also matches CG-RFA-006, CG-TRG-005, CG-CMP-002, CG-TRL-003, CG-RPL-002, CG-TRH-005, CG-RPL-004, CG-PLT-011, CG-PLT-034

  FDA has sent warning letters to telehealth and online sellers over marketing of compounded GLP-1 drugs and unapproved peptides. Compounded drugs are not FDA approved, and these products raise misbranding and unapproved-drug issues.

  Source. FDCA 503A and 503B; FDA warning letters to telehealth firms on compounded GLP-1 marketing

  Safer wording.

Same active ingredient as Wegovy. Lose 20 pounds in 30 days, guaranteed.

• Blocks approvalCG-REG-006Also matches CG-RFA-006, CG-TRI-008, CG-PLT-011, CG-PLT-034

  Compounded drugs are not FDA approved and are not the same as, or generics of, the brand product. Telehealth sellers have received FDA warning letters for these claims.

  Source. FDCA 503A and 503B; FDA warning letters to telehealth firms on compounded GLP-1 marketing; FTC Act section 5

  Safer wording. Say the medication is compounded, that it is not FDA approved, and that a licensed clinician decides whether it is appropriate.

• Blocks approvalCG-TRL-007Also matches CG-PLT-025, CG-PLT-018, CG-ABS-007, CG-ABS-001

  Promising effortless fat loss, fixed amounts of weight lost in a short time, or eating without restriction while losing weight is an unsubstantiated and misleading weight-loss claim.

  Source. FTC Act section 5; FTC Health Products Compliance Guidance (2022); FTC weight-loss advertising enforcement (e.g. Operation Big Fat Lie, Red Flag guidance on weight-loss claims)

  Safer wording. Remove claims of effortless or rapid loss. Say that results vary and depend on diet, activity and medical supervision, and cite evidence for any number.

Reverse your diabetes with our GLP-1 program.

• Blocks approvalCG-DIS-004Also matches CG-TRA-001, CG-TRE-001, CG-TRI-001, CG-TRK-004, CG-DIS-016, CG-PLT-013, CG-PLT-035, CG-PLT-001, CG-PLT-034

  Claiming to reverse a disease or its damage is an efficacy and disease claim.

  Source. FTC Health Products Compliance Guidance; 21 CFR 101.93(g)

  Safer wording. Describe the lifestyle or care support offered without promising reversal.

Our compounded tirzepatide is FDA approved and clinically proven to melt fat.

• Blocks approvalCG-REG-007Also matches CG-TRC-001, CG-REG-001, CG-PLT-011, CG-PLT-034

  FDA has sent warning letters to telehealth and online sellers over marketing of compounded GLP-1 drugs and unapproved peptides. Compounded drugs are not FDA approved, and these products raise misbranding and unapproved-drug issues.

  Source. FDCA 503A and 503B; FDA warning letters to telehealth firms on compounded GLP-1 marketing

  Safer wording.

• Blocks approvalCG-EFF-001

  Proof claims need competent and reliable scientific evidence, usually human clinical testing.

  Source. FTC Health Products Compliance Guidance (2022); FTC Act section 5

  Safer wording. Cite the specific study (population, result, year) or say what the product contains instead.

• Blocks approvalCG-TRL-007Also matches CG-EFF-007

  Promising effortless fat loss, fixed amounts of weight lost in a short time, or eating without restriction while losing weight is an unsubstantiated and misleading weight-loss claim.

  Source. FTC Act section 5; FTC Health Products Compliance Guidance (2022); FTC weight-loss advertising enforcement (e.g. Operation Big Fat Lie, Red Flag guidance on weight-loss claims)

  Safer wording. Remove claims of effortless or rapid loss. Say that results vary and depend on diet, activity and medical supervision, and cite evidence for any number.